Top Markets
#1 Bitway Bitway +46.14%
#2 Wrapped STX (Velar) Wrapped STX (Velar) +41.04%
#3 Pons Pons +35.97%
#4 Starpower Starpower +35.36%
#5 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +27.38%
#6 Ocean Protocol Ocean Protocol +20.20%
#7 SkyAI SkyAI +18.33%
#8 Mubarak Mubarak +18.32%
#9 StonkBroker StonkBroker +16.81%
#10 aelf aelf +16.32%
Coin of the day
Bitway Bitway
Paramètres
Langue
FRANçAIS
Devise
USD
Thème
Ulisse Biomed S.p.A. Ulisse Biomed S.p.A.

Ulisse Biomed S.p.A.

UBM
Classement en actions #29601
Ulisse Biomed S.p.A. is an Italy-based biotechnology enterprise specializing in... Ulisse Biomed S.p.A. is an Italy-based biotechnology enterprise specializing in healthcare diagnostics. The company develops and markets a diverse range of innovative platforms and products designed for disease detection. Central to its offerings is the Sagitta platform, which encompasses specialized tests such as Ladymed/HPV Selfy for human papillomavirus screening, CoronaMelt for identifying SARS-CoV-2, and CoronaMelt Var for detecting and genotyping SARS-CoV-2 variants. Sagitta also provides UlisseFaster, a vital reagent used for the pre-treatment of biological samples, alongside various diagnostic tools for sexually transmitted infections and for detecting HPV associated with oropharyngeal cancers. Beyond Sagitta, Ulisse Biomed boasts the NanoHybrid platform, an advanced multi-modal biomolecule system that utilizes DNA/PNA technology to directly identify specific antibodies and protein analytes from serum or whole blood samples. Its portfolio is further enhanced by the Aptavir platform, dedicated to the development and manufacturing of synthetic nucleic acid molecules aimed at curtailing the infectiousness of pathogens. Established in 2015, Ulisse Biomed S.p.A. operates from its headquarters in Udine, Italy.
Prix de l'action
$0.93739396
Dernière synchronisation: 2026-01-08
Capitalisation boursière
$20.44M
Changement (1 jour)
0.60%
Changement (1 an)
-6.88%
Pays
IT
Échange Ulisse Biomed S.p.A. (UBM)

Catégorie

Healthcare
Historique du prix de l'action pour Ulisse Biomed S.p.A. (UBM)
Prix de clôture le plus élevé : $0.94 le 2026-01-01

Prix de clôture le plus bas : $6.72 le 2021-08-01
Historique du prix de l'action de Ulisse Biomed S.p.A. de 2021 à 2026
Performance annuelle du prix de l'action
Année Performance
2026 (TTM) 14.85%
2025 13.59%
2024 -56.85%
2023 70.06%
2022 -71.69%
2021 0.00%
Prix de l'action pour des entreprises similaires ou concurrentes
Entreprise Prix de l'action Variation 1a% Pays
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $544.11 39.24%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $1.02K 56.01%
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $144.46 417.59%
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $117.42 -19.34%
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $753.80 8.66%
CH